Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.

about

Clinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancer Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis.

P2860

Q33672843-4D2E4828-46B8-4196-8F57-9266EC384792 Q46251162-79B61ADB-ED2C-4D07-9E3E-5A71559B0C47

P2860

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.

Item

http://www.wikidata.org/entity/Q36648866

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical utility of HER2 asses ...... resection for gastric cancer.

@ast

Clinical utility of HER2 asses ...... resection for gastric cancer.

@en

type

Item

label

Clinical utility of HER2 asses ...... resection for gastric cancer.

@ast

Clinical utility of HER2 asses ...... resection for gastric cancer.

@en

prefLabel

Clinical utility of HER2 asses ...... resection for gastric cancer.

@ast

Clinical utility of HER2 asses ...... resection for gastric cancer.

@en

P1476

Clinical utility of HER2 asses ...... resection for gastric cancer.

@en

P2093

Dazhi Xu

http://www.w3.org/2001/XMLSchema#string

Haibo Qiu

http://www.w3.org/2001/XMLSchema#string

Pengfei Xu

http://www.w3.org/2001/XMLSchema#string

Shangxiang Chen

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Xiaowei Sun

http://www.w3.org/2001/XMLSchema#string

Xuechao Liu

http://www.w3.org/2001/XMLSchema#string

Yingbo Chen

http://www.w3.org/2001/XMLSchema#string

Youqing Zhan

http://www.w3.org/2001/XMLSchema#string

Yuanfang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.

Current issues and future perspectives of gastric cancer screening.

Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative Resection.

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.

New developments in the treatment of metastatic gastric cancer: focus on trastuzumab

Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients.

P304

949-958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S100979

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jianjun Liu

P577

2016-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27013889

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

4777257

http://www.w3.org/2001/XMLSchema#string

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.

about

P2860

P2860

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932